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amplification hypothesis, doubly phosphorylated pep-
tides corresponding to individual CD3 ITAMs bind with
similar nanomolar affinities to the tandemly arranged
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Alain Trautmann,² Hai-Tao He,* SH2 domains found in ZAP-70 (Koyasu et al., 1994; Isa-
kov et al., 1995; Bu et al., 1995; Vely et al., 1997; OttingerBernard Malissen,* and Marie Malissen*³
*Centre d'Immunologie et al., 1998), opening the possibility for a fully phosphory-
lated TCR/CD3 complex to recruit as many as ten ZAP-INSERM-CNRS de Marseille-Luminy
Case 906 70 molecules. In addition to their contribution to signal
amplification, CD3 ITAMs may also assume distinct func-13288 Marseille Cedex 9
France tions. Considering that YXXL/I sequences exhibit sub-
stantial variability at position Y 1 1 and Y 1 2 and that²Laboratoire d'Immunologie Cellulaire
UMR CNRS 7627 these very residues contribute to determine the binding
specificity for SH2 domains, it has been suggested thatCERVI
83 Bd de l'HoÃ pital each of the ITAMs is likely to recruit unique SH2-con-
taining targets and serve nonredundant signaling func-75013 Paris
France tion during T cell activation. Three lines of experiments
are consistent with this view. First, synthetic phospho-
peptides corresponding to individual CD3 ITAMs bind
differentially to adaptors such as Shc, Grb-2, or the p85Summary
regulatory subunit of phosphoinositol 39 kinase (John-
son et al., 1995; Osman et al., 1996; de Aos et al., 1997;We evaluated the importance of CD3-z ITAMs in T cell
Ottinger et al., 1998). However, these studies are notresponses by breeding the P14 transgenic TCR into
entirely congruent (compare Osman et al. [1996] and demice in which CD3-z chains lacking all or part of their
Aos et al. [1997]), and the biological relevance of theseITAMs were genetically substituted for wild-type CD3-z
interactions, which occur with micromolar affinities aschains. In contrast to the H-Y TCR, the P14 TCR per-
opposed to the nanomolar affinities seen with ZAP-70/mitted the development of peripheral CD81 T cells har-
Syk tandem SH2-domains, remains to be validated in aboring signaling-defective CD3-z subunits. The ab-
cellular context in which other SH2-containing proteinssence of functional CD3-z ITAMs did not reduce the
(e.g., ZAP-70) compete for the same ITAMs (Osman etspectrum of activation events and effector functions
al., 1995). Second, it has been shown that the CD3-gdethat constitute the normal attributes of mature CD81
module of the TCR/CD3 complex is unable to substituteT cells. The only detectable differences were quantita-
for CD3-z to sustain activation initiated via the Thy-1,tive and noted only when T cells were challenged with
Ly-6, or CD2 molecules (Moingeon et al., 1992; Wegenersuboptimal peptide concentrations. Therefore, the
et al., 1992). Third, cross-linking of chimeric receptorsITAMs present in the CD3-gde module are sufficient
containing the cytoplasmic tail of CD3-e or CD3-z re-for qualitatively normal TCR signaling and those pres-
sulted in distinct signaling outcomes as detected byent in CD3-z have no exclusive role during T cell acti-
analysis of inducible protein tyrosine phosphorylationvation.
(Letourneur and Klausner, 1992), intracellular free cal-
cium ([Ca21]i) mobilization (Jensen et al., 1997), or activa-
tion-induced cell death (AICD) (CombadieÁ re et al., 1996).Introduction
However, in other instances, the same CD3-e- and CD3-
z-based chimeras were found equally capable of elic-The transducing subunits of the T cell antigen receptor
iting early and late T cell activation events (Letourneur(TCR) contain one (CD3-g, -d, and -e) or three (CD3-z)
and Klausner, 1992; van Oers et al., 1998).copies of a conserved cytoplasmic sequence termed the
With three concatenated ITAMs, denoted a, b and c,immunoreceptor tyrosine-based activation motif (ITAM).
and thus six potential tyrosine phosphorylation sites,Common to each ITAM is a pair of YXXL/I sequences
denoted a1, a2, b1, b2, c1, and c2, CD3-z can generate(where X corresponds to a variable residue) separated
many discrete phospho-species. For instance, it hasby 6±8 variable amino acids. To exert their signaling
been shown that resting T cells constitutively expressfunctions, ITAMs cooperate with nonreceptor tyrosine
a 21 kDa phosphoform of CD3-z (p21) (Madrenas et al.,kinases belonging to the Src and Syk/ZAP-70 families.
1995; Reis e Sousa et al., 1996; Sloan-Lancaster andThe association of the TCR with a constellation of ten
Allen, 1996). After full stimulation of the TCR, phosphory-ITAMs is an intriguing feature that may account for its
lation of p21 increases and a second 23 kDa phospho-zability to sense specific peptide/MHC complexes ex-
species (p23) appears and correlates with ZAP-70 tyro-pressed at only tens or hundreds of copies per anti-
sine phosphorylation and activation. In contrast, aftergen-presenting cell (APC). Consistent with this signal
stimulation with suboptimal TCR ligands, p21 is pro-
duced in large excess over p23 and the associated ZAP-
70 remains unphosphorylated. Therefore, owing to its³ To whom correspondence should be addressed (e-mail:
malissen@ciml.univ-mrs.fr). singular structure among CD3 subunits and to its ability
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to undergo multisite and hierarchichal tyrosine phos- c (c2) was converted into a phenylalanine with the pur-
pose of mimicking an alternative splice form of the CD3-phorylation, CD3-z may constitute a molecular proces-
z/h gene known as CD3-h. In resting T cells, the c2sor capable of translating the variation in the half-lives of
tyrosine constitutes a prominent phosphorylation site,the TCR-ligand interactions into discrete phosphoforms
and its mutation disrupts the hierarchical z phosphoryla-and possibly distinct functional outcomes, depending
tion that normally follows TCR engagement (Neumeisteron the number or quality of the SH2-containing ef-
Kersh et al., 1998). Based on previous studies (Sunder-fectors/adaptors recruited (Neumeister Kersh et al.,
Plassmann et al., 1997), the za12b12c12 mutation should1998). According to this model, differential TCR signal-
prevent docking of ZAP-70 and lead to the synthesis ofing should depend on the integrity of CD3-z ITAMs.
transduction-defective z chains. To formally assess thatAs discussed above, determining whether individual
point, chimeric receptors composed of extracellular do-CD3 ITAMs perform unique or redundant functions has
mains of CD8a or CD25 and of a za12b12c12 cytoplasmicled to somewhat disparate results that may result from
segment were expressed in the BW2 and Jurkat T celldifferences in the activation conditions (most relied on
lines. Upon extensive cross-linking, the correspondingmassive antibody-mediated cross-linking rather than
chimeras were unable to induce signals leading to [Ca21]igenuine antigenic stimulation) or from the use of differ-
mobilization, CD95L expression, and interleukin-2 (IL-2)ent lines of transformed T cells (Hermans and Malissen,
production (Donnadieu et al., 1994; Vignaux et al., 1995).1993; Donnadieu et al., 1994; Steeg et al., 1997; Sahu-
In contrast, chimeras made of a za1b1c22 intracytoplas-quillo et al., 1998; She et al., 1998). By eliminating some
mic segment triggered IL-2 production in amounts thatof the above limitations, reconstitution of mice deficient
were 40-fold less than those elicited by chimeras con-in a given CD3 subunit with transgenes encoding func-
taining wild-type z cytoplasmic tail (Rozdzial et al., 1995).tionally impaired versions of the missing subunit should
The za12b12c12, za1b1c22, and z wild-type (wt) cDNAsconstitute a more appropriate way of assessing the re-
were each introduced into an expression cassette drivenspective function of the various CD3 ITAMs. However,
by the CD2 gene regulatory sequences and used tobecause of the epigenetic mechanisms that shape the
generate transgenic mice. Founders were bred into arepertoire of TCRs expressed on mature T cells, adap-
CD3-z/h2/2 background and selected for their abilitytive responses to certain CD3 mutations can be set in
to restore levels of TCR surface expression comparablemotion during T cell development, and selection of TCRs
to wild-type T cells. Consistent with the data of Shoreswith higher affinity for self-MHC compensate for the
et al. (1994), reconstitution of CD3-z/h2/2 mice with zwt,impeded signaling capacity of TCR/CD3 complexes
za12b12c12, or za1b1c22 transgenes restored both T cellcontaining crippled CD3 subunits. Consistent with this
development and generation of normal numbers of func-view, a transgene encoding a CD3-z polypeptide that
tional peripheral T cells (data not shown). We next fixedlacked all three ITAMs (TgzD67±150) restored complete T
the specificity of the TCR expressed on developing thy-cell development when expressed in CD3-z/h2/2 mice.
mocytes by introducing the P14 transgenic TCR intoHowever, when bred into CD3-z/h2/2 mice in which TCR
CD3-z/h2/2 mice. This TCR recognizes a peptide (p33)variability was neutralized by coexpressing a transgenic
of the lymphocytic choriomeningitis virus (LCMV) glyco-TCR (H-Y TCR) originally calibrated in the context of
protein presented by the MHC class I molecule H-2 Dbnormal TCR/CD3 complexes, the impact of the CD3-
(Pircher et al., 1991). Its expression can be monitoredzD67±150 mutation was readily revealed in that it prevented
with two monoclonal antibodies specific for Va2 (B20.1)positive selection and subsequent development of ma-
and Vb8.1 (KJ16). Thymocytes from P14 3 CD3-z/h2/2ture H-Y TCR1 T cells (Shores et al., 1997). We report
mice express extremely low levels of TCR at their surfacein this work that a transgenic TCR originating from the
and do not develop beyond the double-positive stageP14 CD81 T cell clone can be positively selected in the
of thymic differentiation. In contrast, when separatelyabsence of functional z ITAMs. Therefore, in the case
reconstituted with transgenes encoding zwt, za12b12c12,of TCR displaying a higher affinity than the H-Y TCR,
or za1b1c22 chains, P14 3 CD3-z/h2/2 mice generatedsignals provided by the CD3-gde module may suffice to
P14 TCR-positive CD41CD81 and CD42CD81 thymo-
drive positive selection in the absence of z-mediated cytes in numbers comparable to those found in P14
signals. By permitting the development of normal num- thymi. As shown in Figure 1, the P14 TCR1, CD81 thymo-
bers of peripheral T cells harboring signaling-defective cytes found in each of these genetic backgrounds were
z subunits, the P14 TCR constitutes a particularly appro- capable of populating peripheral lymphoid organs. Con-
priate model to analyze in a physiological situation the sistent with the manner in which we originally selected
role z ITAMs play in TCR signaling. the various z transgenic founders, the resulting CD81
peripheral T cells express levels of transgenic TCR al-
most similar to those found in P14 mice (Figure 1, lower
Results panels). It should be stressed that the P14 TCR1, CD81
T cells that develop in zwt, za12b12c12, and za1b1c22
The P14 TCR Allows Development of Mature T Cells backgrounds display levels of CD8 coreceptor identical
in Mice Expressing Transduction-Defective z Chains to those found in P14 mice (Figure 1). Moreover, they
Two mutated z cDNA constructs were developed with colonize the periphery in numbers and with kinetics indis-
the aim of inactivating all or part of the transducing tinguishable from those observed for P14 CD81 T cells
capacities of z. In the first one, denoted za12b12c12, the (data not shown). This contrasts with the CD32 or very low
amino-terminal tyrosine residue of each ITAM was con- T cells that slowly accumulate in the periphery of CD3-
verted into a phenylalanine residue. In the second one, z/h2/2 mice and suggests that the P14 TCR1, CD81 T
cells generated in a za12b12c12 context do not resultdenoted za1b1c22, the carboxy-terminal tyrosine of ITAM
TCR Signaling with Impaired CD3-z ITAMs
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Figure 1. Expression of Transduction-Defective z Subunits Does Not Prevent Development of P14 TCR1, CD81 Peripheral T Cells
Total lymph node cells from P14 mice and P14 3 CD3-z/h2/2 mice reconstituted with za12b12c12, za1b1c22, or wild-type (wt) z subunits were
analyzed by three-color flow cytometry for expression of CD4, CD8, and Va2. For CD4 versus CD8 two-color plots, percentage of CD41 and
CD81 T cells is indicated. For single-color profiles, the filled histograms depict Va2 staining on CD81 T cells and are compared to the level
of Va2 staining found in P14 CD81 T cells (dotted histogram). The position of the window (R1) used to define CD81 cells is shown for the P14
dot plot. Also shown is the percentage of Va2high CD81 T cells. Two founders (VT21.9 and VT 21.48) were analyzed for the za12b12c12 construct.
from rare adaptive events aimed at compensating the T cells normally coexpress FceRIg and CD3-z in their
TCR complexes (Shores et al., 1998). In view of thisexpression of transduction-defective z subunits. There-
fore, the P14 TCR offers the possibility of addressing unexpected finding, the comparative functional studies
discussed below focus on CD81 T cells originating fromex vivo the functional properties of primary T cells ex-
pressing z subunits devoid of functional ITAMs. Consid- za12b12c12, za1b1c22, and P14 mice, as they express
similar levels of P14 TCR/CD3 complexes that differ onlyering that the various z transgenic lines used hereafter
share the same CD3-z/h2/2 and H-2b/b genetic back- at the level of their z subunits.
ground, are heterozygous for the P14 TCR transgene,
and differ only at the level of the z cDNA construct they Effects of the za12b12c12 and za1b1c22 Mutations
on Tyrosine Phosphorylation andexpress, they will be simply denoted as zwt, za12b12c12,
and za1b1c22, whereas P14 TCR transgenic mice will Membrane Microdomain
To analyze the tyrosine phosphorylation status ofbe referred to as P14. Two independent lines of mice
expressing the za12b12c12 constructs (VT21.9 and za12b12c12 and za1b1c22 subunits prior to or following
T cell activation, lymph node T cells were isolated andVT21.48, Figure 1) were used in parallel. Considering that
no significant differences were noticed in their ability to phosphotyrosine antibody immunoblotting of TCR/CD3
immunoprecipitates carried out before or after treatmentrespond to antigen, they have not been discriminated
hereafter. with the protein tyrosine phosphatase inhibitor pervana-
date. In contrast to wild-type z chains expressed in P14
T cells, we were unable to detect any constitutive phos-Subunit Composition of TCR/CD3 Complexes
Containing Wild-Type or Mutated z Chains phorylation of za12b12c12 and za1b1c22 chains (Figure
2C). Consistent with this finding, only the wild-type zAs shown in Figure 2A, the TCR/CD3 complexes ex-
pressed on the surface of zwt and za12b12c12 lymph chains present in P14 T cells were constitutively associ-
ated with nonphosphorylated ZAP-70. Following per-node T cells display a normal complement of TCRab,
CD3-g, CD3-d, and CD3-e subunits. In za12b12c12 T cells, vanadate-treatment of P14 T cells, there was a marked
increase in the tyrosine phosphorylation of the CD3-ethe spot migrating at approximately 32 kDa in nonre-
duced dimension and falling off the diagonal as a spe- and CD3-z subunits. The single tyrosine substitution
introduced in the za1b1c22 subunits still allowed theircies of z16 kDa corresponds to za12b12c12 dimers
(Figure 2B). Three disulfide dimers were specifically im- phosphorylation following pervanadate treatment and
resulted in a single prominent phosphorylated z speciesmunoprecipitated from lysate of zwt T cells. Two of them
migrated at positions predicted for TCR ab and zz that migrated slightly below 21 kDa (Figure 2C). In con-
trast, pervanadate treatment of za12b12c12 T cells re-dimers, whereas the third one migrated at 20 kDa in
nonreduced dimension. Immunobloting with antisera sulted in the pronounced phosphorylation of CD3-e and
in no detectable phosphorylation of the za12b12c12 sub-specific for CD3-z or the g chain of the high-affinity
receptor for immunoglobulin (FceRIg) identified this last unit. Substantial amounts of phosphorylated ZAP-70
were found associated with TCR complexes immu-species as made of disulfide-linked z and FceRIg chains.
As shown in Figure 2B, FceRIg expression was strictly noprecipitated from pervanadate-treated za12b12c12 T
cells. Considering that ZAP-70 does not bind to unphos-limited to zwt transgenic T cells. This erratic expression,
further corroborated by RNA-PCR analysis (data not phorylated CD3-z ITAMs, the ZAP-70 molecules copre-
cipitating with za12b12c12-containing TCR complexesshown), is surprising, as only restricted populations of
Immunity
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Figure 2. Immunoprecipitation and Immunoblotting of TCR/CD3 Complexes Expressed on Lymph Node T Cells from P14, zwt, za12b12c12,
and za1b1c22 Mice
(A) Two-dimensional (nonreducing/reducing) 12% SDS-PAGE of TCR/CD3 chains precipitated by 2C11 (anti-CD3-e) antibody from lysates of
radioiodinated T cells isolated from zwt or za12b12c12 lymph nodes. Relative positions of molecular weight standards are indicated (in kilodaltons)
as well as the positions of TCR/CD3 chains.
(B) Characterization of z-containing dimers expressed in lymph node T cells from P14 and various z transgenic lines. Lysates from indicated
T cells were immunoprecipitated with the 2C11 antibody. Immunoprecipitates were analyzed on nonreducing 12% SDS-PAGE and immunoblot-
ted with either an anti-z serum (387) or with an antiserum specific for the FceRIg chain. z homodimers (z-z) and z-FceRIg heterodimers migrate
at approximately 32 kDa and 25 kDa, respectively. As shown in (A) and (B), the za12b12c12 chain migrated faster than the wild-type z chain in
both nonreduced and reduced dimensions.
(C) Phosphotyrosine antibody immunoblot of TCR/CD3 immunoprecipitates prior to or following pervanadate-treatment. The indicated lymph
node T cells were either left untreated (minus) or treated (plus) with pervanadate for 7 min at 378C and subsequently lysed in Brij 96±containing
buffer. TCR/CD3 complexes were immunoprecipitated with the anti-CD3-e antibody 2C11. Precipitates were resolved on a 7%±17% reducing
SDS-PAGE gradient gel and immunoblotted with an anti-phosphotyrosine antibody (4G10, top panel). To identify the different phospho-
species, the blot was subsequently stripped and reprobed with antibodies specific for z (middle panel) or with an antiserum specific for ZAP-
70 (lower panel). The epitope recognized by the anti-z antibody H146±968 encompasses the C terminus of ITAM-c and is substantially affected
by the za1b1c22 mutation. Accordingly, za12b12c12 and za1b1c22 polypeptides were quantified using H146±968 and the anti-z serum 387,
respectively. Positions of the molecular weight standards are indicated.
(D) Tyrosine phosphorylated proteins present in DIMs of za12b12c12, za1b1c22, and P14 thymocytes. Thymocytes were incubated at 378C for
5 min with either an anti-CD3-e antibody (2C11; lanes labeled with a plus) or a negative control antibody (RB6±8C5, lanes labeled with a
minus). Postnuclear supernatants were solubilized in Brij 58 and fractionated on sucrose gradient. Fractions corresponding to DIMs were
pooled and identical amounts of total proteins were analyzed by SDS-PAGE. Following immunoblotting with anti-phosphotyrosine antibody
(4G10), the membrane was subsequently stripped and reprobed with antibodies against Lck, LAT, or z. Quantitative analysis of hybridizing
bands indicated that the amounts of Lck and LAT associated with the za11b12c12, za1b1c22, and P14 DIMs varies by less than a factor of 1.3.
In the experiment shown, the degree of inducible tyrosine phosphorylation of LAT is approximately 2-fold more pronounced in za1b1c22 DIMs
than in P14 and za12b12c12 DIMs. However, this was not a recurrent finding. As noted in (C), the fact that the za1b1c22 species is poorly
recognized by antibody H146±968 precludes genuine quantitative analysis of the z species associated with the various DIMs.
are likely anchored via the phosphorylated CD3-e ITAM. proper TCR signaling (Montixi et al., 1998). To examine
whether z ITAMs play a role in the distribution of LckTherefore, the inducible tyrosine phosphorylation pat-
tern observed in za12b12c12 lymph node T cells is remi- and LAT within DIMs, DIMs from za12b12c12, za1b1c2,
and P14 thymocytes were analyzed by SDS-PAGE andniscent of that found in thymocytes expressing z sub-
units that lack most of their cytoplasmic segments immunoblotting. In DIMs isolated from P14 thymocytes
(and only from P14 thymocytes), a proportion of z mole-(zD67±150; van Oers et al., 1998) and suggests that regard-
less of the presence of functional CD3-z ITAMs, ZAP- cules was constitutively phosphorylated and migrated
at 21 kDa. Following TCR ligation, the DIMs present in70 can dock on phosporylated CD3-gde modules and
undergo tyrosine phosphorylation. P14 thymocytes showed an increase in p21 tyrosine
phosphorylation and the appearance of a p23 species.Lck and LAT constitute critical proximal components
of the TCR signaling cassette. Due to posttranslational In marked contrast, in DIMs isolated from za12b12c12
thymocytes, TCR ligation resulted in no detectablelipid modification, these proteins are constitutively
targeted to glycolipid-enriched microdomains of the phosphorylation of the mutated z subunits. In the case
of DIMs isolated from activated za1b1c22 thymocytes,plasma membrane (Zhang et al., 1998). Based on their
behavior on sucrose gradient, these microdomains are only prolonged exposures revealed the presence of
phosphorylated za1b1c22 subunits that migrated at aalso referred to as low-density detergent-insoluble
membranes (DIMs). During T cell activation, DIMs ap- position slightly faster than 21 kDa (data not shown).
Before or after TCR ligation, DIMs isolated from P14,pear to nucleate many signaling proteins required for
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za12b12c12, and za1b1c22 thymocytes contain similar
amounts of Lck and LAT molecules (Figure 2D). More-
over, the LAT molecules present in these various DIMs
showed no appreciable constitutive phosphorylation. In
contrast, following TCR ligation a substantial tyrosine
phosphorylation of LAT was noted in DIMs isolated from
P14, za12b12c12, and za1b1c22 thymocytes. Taken to-
gether, these data suggest that in the absence of intact z
ITAMs, a number of molecules involved in TCR signaling
events (e.g., CD3-e, ZAP-70 and LAT) are still capable
of undergoimg inducible tyrosine phosphorylation fol-
lowing TCR ligation. Furthermore, they indicate that criti-
cal TCR proximal effectors such as Lck, ZAP-70, and
LAT are not overexpressed in za12b12c12 and za1b1c22
T cells relative to P14 T cells.
z ITAMS Are Not Necessary to Elicit Early Figure 3. Antigen-Induced Ca21 Responses in P14 and za12b12c12
and Late T Cell Activation Events CD81 T Cells
We next compared the functional capacity of LCMV- H-2 Db-positive, CD3-e-deficient spleen cells were pulsed overnight
specific CD81 T cells that developed in za12b12c12, with the p33 or M3V peptides. Fura-2-loaded T cells were added
on the APC monolayer and Ca21 responses monitored in individualza1b1c22, and P14 mice. In most experiments, CD81 T
cells during a 20 min recording period.cells were purified from lymph nodes. Nearly all of them
(A±C) Each curve represents Ca21 response of an average of sevenwere naive resting T cells (i.e., they displayed a CD252
responding cells (i.e., cells showing a Ca21 peak of at least 200 nM),
CD44low, CD62Lhi, and CD69- phenotype), and over 90% and time zero corresponds to the beginning of Ca21 response of
coexpressed Va2 and Vb8. CD81 T cells were stimulated individual cells.
with H-2 Db-positive APC pulsed with graded concentra- (D) Average delays (6 SEM) between arrival of T cells in the plane
of the APC monolayer and the beginning of a Ca21 response aretions of peptides p33, M3V, L3V, or AV. p33 constitutes
shown.a strong agonist for the P14 TCR, whereas peptides
M3V and L3V are two naturally occuring single amino
acid variants of p33 that behave as weak agonists
antigen-induced Ca21 responses that were both qualita-(Pircher et al., 1991; Bachmann et al., 1998). An adenovi-
tively and quantitatively similar to those induced in therus peptide (AV) known to efficiently bind to H-2 Db
presence of a normal complement of CD3 ITAMs.(Sebzda et al., 1996) was used as a negative control.
The H-2 Db-positive spleen cells used as APC in some
TCR/CD3 Downregulation and Expressionexperiments derive from CD3-e-deficient mice and lack
of Surface Activation Markersdetectable T cells.
T cells from za12b12c12, za1b1c22, and P14 mice were
cultured with RMA-S cells pulsed with graded doses of
peptides p33, M3V, L3V, and AV. After 15 hr, cells wereCa21 Responses
P14 and za12b12c12 CD81 T cells were compared for harvested and stained for Va2, CD3-e, CD25, or CD69
expression. Figure 4 shows the expression of these vari-their ability to increase [Ca21]i following stimulation by
H-2 Db-positive spleen cells pulsed with p33 or M3V. ous markers on gated CD81 T cells and make four points.
First, the percentage of CD81 T cells upregulating CD25[Ca21]i quantitation was performed at the single cell level
by imaging Fura-2 fluorescence. Figures 3A, 3B, and 3C or CD69, as well as the percentage of TCR downregula-
tion, depended on the concentration of antigenic pep-show the average Ca21 responses of the two types of
cells. Full Ca21 responses were triggered in both P14 tide. Second, in contrast to p33, M3V failed to trigger
maximal TCR internalization. Third, with regard to CD25and za12b12c12 T cells when p33 was used at 4 3 1028 M
(Figure 3A). Importantly, the absence of z ITAMs affected and CD69 upregulation, the concentrations at which
M3V and L3V were half-maximally effective (i.e., theirneither the maximum intensity nor the persistence of
the Ca21 response. The partial responses induced in EC50 values) were higher than that observed for p33.
Fourth, no TCR/CD3 downregulation and no CD25 orboth P14 and za12b12c12 T cells by a lower concentration
of p33 (Figure 3B) or the weak agonist M3V (Figure 3C) CD69 upregulation were seen on CD41 T cells or with
the negative control peptide AV (data not shown). Impor-were almost indistinguishable. We next measured the
delays separating the arrival of T cells in the plane of tantly, upon challenge with any of the three antigenic
peptides, T cells from za12b12c12and za1b1c22 micethe APC monolayer and the beginning of individual Ca21
responses. This delay corresponds to the time needed were as efficient as P14 T cells at downregulating their
TCR/CD3 complexes and at upregulating the CD25 andby a T cell to find a partner and engage in a productive
interaction. For stimulations performed with an optimal CD69 molecules.
concentration of p33 peptide (4 3 1028 M; Figure 3D),
this delay was 6±7 minutes both for P14 and za12b12c12 Proliferation and Cytokine Secretion
As shown in Figure 5A, P14 CD81 T cells strongly prolif-T cells and was not significantly different when using
M3V or a suboptimal concentration of p33. Therefore, erated in response to APC pulsed with p33 peptide.
Peptide L3V induced a weaker proliferation and peptideLCMV-specific CD81 T cells lacking z ITAMs display
Immunity
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Figure 4. TCR Downregulation and Expression of CD25 and CD69 on CD81 T Cells Isolated from P14, za12b12c12, and za1b1c22 Mice and
Stimulated with the p33 Agonist Peptide or Either of Its Weak Agonist Derivatives, M3V or L3V
RMA-S cells (2.5 3 105) were prepulsed with graded concentrations of antigenic peptides and cultured with T cells (1.5 3 106) purified from
the various transgenic mice. After 12±15 hr, levels of TCR/CD3 complexes, CD25, and CD69 were determined by flow cytometry on gated
CD81 T cells. One representative experiment of two is shown.
(A) TCR downregulation. Data are given as percent mean fluorescence intensity of T cells cultivated for 12±15 hr with RMA-S cells pulsed
with an irrelevant H-2 Db-binding peptide (AV). Similar values were obtained by using either anti-Va2 or anti-CD3-e antibodies.
(B and C) CD69 and CD25 upregulation. Data show the percent of CD691 (B) or CD251 (C) cells found among CD81 T cells.
M3V an intermediate level of proliferation. When chal- za12b12c12 or za1b1c22 T cells consistently yielded 2-fold
less CD81 T cells than cultures involving P14 T cellslenged with either of these three peptides, the za12b12c12
and za1b1c22 CD81 T cells showed dose-response (data not shown), an observation in line with the fact that
the proliferative responses of za12b12c12 and za1b1c22 Tcurves almost superimposable with those obtained us-
ing P14 CD81 T cells. However, the P14 CD81 T cells cells to nanomolar concentrations of p33 were repro-
ducibly lower than that of P14 T cells (Figure 5A).consistently proliferated in response to a 10210 M con-
centration of p33 peptide, whereas no detectable prolif-
eration was observed at the same peptide concentration Antagonistic Ligands Do Act
in the Absence of z ITAMsfor za12b12c12 CD81 T cells.
As shown in Figure 5B, the ability to secrete inter- Two variants of peptide p33, denoted S4Y and V4YL6F,
have been described as antagonists for the P14 TCRferon-g (IFNg) and IL-2 in response to graded concentra-
tion of p33 was clearly not dependent on the presence (Bachmann et al., 1998). Peptides S4Y and V4YL6F have
relative binding affinities for H-2 Db that are similar toof intact z ITAMs. However, again, the za12b12c12 T cells
responded less effectively than P14 CD81 T cells when p33 and to the negative control peptide AV. Peptides
S4Y and V4YL6F failed to trigger proliferation of P14challenged with nanomolar or subnanomolar concentra-
tions of p33. CD81 T cells at concentrations up to 1024 M but can
nonetheless act as specific TCR antagonists. To assess
whether antagonistic activity does require z ITAMs, H-2Cytotoxic T Cell Responses
T cells from za12b12c12, za1b1c22, and P14 mice were Db±positive APC were prepulsed with a suboptimal dose
of p33, washed, and plated with graded concentrationsstimulated in vitro with a suboptimal dose of p33 and,
after 3 days, assayed for their cytolytic activity on of S4Y or V4YL6F. CD81 T cells purified from zwt,
za12b12c12, za1b1c22, and P14 mice were subsequentlyRMA-S target cells pulsed with a suboptimal concentra-
tion of p33 (1029 M). As shown in Figure 5C, the resulting added and their proliferation assessed two days later.
As shown in Figure 6A, S4Y and V4YL6F consistentlyza12b12c12, za1b1c22, and P14 cytotoxic T cells were
all capable of efficiently lysing target cells pulsed with inhibited zwt, za1b1c22, and P14 T cell proliferation in
a dose-dependent manner. In contrast, no such effectpeptides p33, M3V, or L3V. However, cultures containing
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Figure 5. Proliferative Responses, Cytokine
Secretion, and In Vitro Induction of Cytolytic
Effectors
(A) H-2 Db-positive, CD3-e-deficient spleen
cells (5 3 105) were pulsed for 2 hr with graded
concentrations of p33 agonist or of the weak
agonists M3V or L3V and subsequently cul-
tured with purified CD81 T cells isolated from
the various transgenic mice. After 48 hr, pro-
liferation was assessed by pulsing cultures
with [3H]TdR for 8 hr. Data correspond to the
mean of triplicate cultures.
(B) H-2 Db-positive, CD3-e-deficient spleen
cells (1.5 3 106) were prepulsed with graded
concentrations of p33 peptide and subse-
quently cultured with CD81 T cells (5 3 105)
isolated from the various transgenic mice.
After 40 hr, supernatants were assayed for
cytokine contents as described in Experi-
mental Procedures. One representative ex-
periment of three is shown.
(C) Spleen cells (1.5 3 106) from P14,
za12b12c12, or za1b1c22 mice were stimulated
with irradiated C57BL/6 spleen cells pulsed
with a suboptimal concentration (1029 M) of
p33 peptide. After 3 days, cells present in
the culture were counted and their cytotoxic
activity tested on 51Cr-labeled RMA-S cells
pulsed with p33 (1029 M), M3V (1027 M), or L3V
(1026 M). An irrelevant H-2 Db-binding peptide
(AV) was included in each experiment to con-
trol the specificity of the induction and ef-
fector phases (data not shown). One repre-
sentative experiment of two is shown.
was seen with the control Db-binding peptide AV, dem- the AV peptides. After 70 hr, cells were harvested and
stained for CD95 and CD95L. Figure 7 shows the expres-onstrating that the inhibitory effect of S4Y and V4YL6F
was due to TCR antagonism rather than competition for sion of these two markers on gated CD81 T cells. T
cells from za12b12c12 and za1b1c22 mice were almostMHC molecules. As previously documented (Figure 5A),
CD81 T cells isolated from za12b12c12 mice were unable as efficient as P14 T cells at upregulating CD95 and
CD95L. In contrast, no CD95 or CD95L upregulation wasto proliferate when challenged with the suboptimal dose
of p33 required to assess the antagonistic properties of seen on CD81 T cells stimulated with the AV peptide or
on CD41 T cells (data not shown). Therefore, z ITAMsS4Y and V4YL6F. To circumvent this limitation, we took
advantage of the fact that in some experiments P14, are sufficient (Vignaux et al., 1995) but not necessary
(Figure 7) for inducing CD95 and CD95L upregulation.zwt, and za12b12c12 CD81 T cells were all capable of
responding to the same suboptimal dose (1029 M) of the
weak agonist M3V. Under these conditions, proliferative Discussion
response of za12b12c12 T cells was, however, consis-
tently lower than that of P14 or zwt T cells (4500 cpm Based on the exon±intron organization of the genes
coding for ITAM-containing molecules, we have sug-versus 11000 cpm in the experiment shown in Figure
6B). In 3 of 3 experiments, S4Y and V4YL6F inhibited gested that most ITAMs stem from a primordial building
block made of two exons (Wegener et al., 1992). Theproliferation of za12b12c12, zwt, and P14 T cells, whereas
no such effect was seen with the control peptide AV YXXL/I sequences found in the present-day ITAMs ex-
hibit substantial divergence at position Y 1 1 and Y 1(Figure 6B). Therefore, the P14 TCR antagonists S4Y
and V4YL6F can inhibit T cell proliferation triggered by 2 and may differ both quantitatively and qualitatively in
their signaling function. Therefore, during the diversifica-the weak agonist M3V irrespective of the presence of z
ITAMs. tion process that affected ITAMs, some may have lost
their functional autonomy (i.e., the ability to be first an
effective substrate for Src-family kinases and then be-z ITAMs Are Not Required for Induction
of Fas and FasL come competent to recruit the Syk/ZAP-70 kinases).
Once phosphorylated, the FceRIb and FceRIg subunitsThe upregulation of CD95 (Fas) and CD95L (Fas-L) that
follows signaling through the TCR is likely to account of FceRI constitute an example of this specialization
process in that they differentially interact with the ki-for the ability of activated T cells to exert Fas-based
T cell±mediated cytotoxicity and to undergo AICD. To nases Lyn and Syk, respectively (Lin et al., 1996; Vonakis
et al., 1997). Therefore, under physiological condition,analyze the role of z ITAMs in the induction of CD95 and
CD95L, T cells from za12b12c12, za1b1c22, and P14 mice proper FceRI functioning requires cooperative interac-
tions between the FceRIb and FceRIg subunits. Whetherwere stimulated with APC pulsed with either the p33 or
Immunity
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Figure 6. The Antagonists S4Y and V4YL6F Do Not Require Integrity of z ITAMs to Inhibit T Cell Proliferation Triggered by the Weak Agonist
M3V
(A) Spleen cells from H-2 Db-positive, CD3-e-deficient mice were isolated, exposed to 2,000 cGy, prepulsed with a suboptimal concentration
(10210 M) of the strong agonist p33, washed twice, and added to microtiter plate containing graded concentrations of S4Y, V4YL6F, or AV
peptides. After preincubation for 30 min at 378C, CD81 T cells purified from P14, zwt, za12b12c12, and za1b1c22 transgenic mice were added.
Plates were incubated at 378C, and after 48 hr proliferation was assessed by pulsing cultures with [3H]TdR for 16 hr. Data represent the mean
of triplicate cultures. Note that peptide p33 failed to trigger za12b12c12 T cell proliferation at concentrations below 1029 M (see Figure 5A).
One representative experiment of three is shown.
(B) Proliferative response of P14, zwt, and za12b12c12 T cells in response to a suboptimal dose (1029 M) of M3V is antagonized by peptides
S4Y or V4YL6F. CD3-e-deficient splenocytes were irradiated, pulsed with M3V (1029 M), washed, and incubated with peptides S4Y, V4YL6F,
and AV. CD81 T cells isolated from P14, zwt, or za12b12c12 mice were added and their proliferation was determined 48 hr later. One representative
experiment of three is shown. Note that the S4Y, V4YL6F, and AV peptides have relative affinities for H-2 Db similar to M3V (Bachmann et al.,
1997).
a similar situation applies to the TCR/CD3 complex is The reaction leading from basal (p21) to full phosphor-
ylation (p23) of CD3-z proceeds in a hierarchical modeworth considering, since the singular structure of the
CD3-z subunit as well as its ability to be constitutively and by way of discrete intermediates (Neumeister Kersh
et al., 1998). It has been hypothesized that each of thephosphorylated may have conferred on it a unique role
in TCR firing. To determine the importance of z ITAMs intermediate phospho-z species that accumulate in re-
sponse to suboptimal or antagonistic ligands may dis-when T cells are challenged by full agonist, weak ago-
nist, and antagonist peptides, we bred the P14 TCR play some selectivity for unique intracytoplasmic ef-
fectors/adaptors and confer to the TCR complexes theinto mice in which z chains lacking all or part of their
transducing capacities have been substituted for en- ability to trigger distinct signaling pathways (Neumeister
Kersh et al., 1998). It thus came as a surprise to finddogenous, wild-type z chains. We showed that the ab-
sence of functional z ITAMs does not reduce the spec- that a TCR deprived of functional CD3-z ITAMS and its
wild-type counterpart had similar capacity for differen-trum of activation events and effector functions that
constitute the normal attributes of mature activated tial responsiveness (for instance, using the weak agonist
L3V at 1027 M, both za12b12c12 and P14 T cells readilyCD81 T cells. Consistent with a recent report focusing
on AICD (She et al.,1998) and with the fact that the upregulated CD25 and CD69 but failed to proliferate).
Furthermore, we showed that two antagonists were ca-reconstitution of CD3-z/h-deficient mice with za12b12c12
polypeptides did not result in autoimmune lymphopro- pable of inhibiting T cell proliferation triggered by a weak
agonist irrespective of the presence of functional CD3-zliferative syndrome akin to that found in Fas-deficient
mice (unpublished data), we also showed that functional ITAMs. The za1b1c22 subunit has the theoretical possi-
bility to bind ZAP-70 via either of its two unmutatedz ITAMs are clearly dispensable for antigen-mediated
upregulation of CD95 and CD95L. These observations ITAMs. However, we showed that substitution of tyro-
sine c2 by a phenylalanine has profound repercussionssuggest that in primary T CD81 lymphocytes, proper
TCR functioning does not depend on cooperative inter- on the ability of za1b1c22 to become phosphorylated
following TCR/CD3 cross-linking. Consistent with dataactions between the CD3-gde and CD3-z modules.
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Figure 7. Antigen-Mediated Stimulation of the P14, za12b12c12, and za1b1c22 T Cells Induces Surface Expression of CD95 and CD95L
T cells indicated in the left margin were stimulated with CD3-e-deficient spleen cells that were irradiated and pulsed with the p33 agonist
peptide or an irrelevant H-2 Db-binding peptide (AV). After 70 hr, levels of CD95 and CD95L present on CD81 T cells were determined by flow
cytometry. Also shown is the percentage of CD95- or CD95L-positive CD81 T cells.
obtained with the za12b12c12 T cells, the impaired phos- do not constitute a rate-limiting factor for proper func-
tioning of the P14 TCR (see also Shores et al. [1994]phorylation of za1b1c22 was without measurable effect
on the functional properties of the P14 TCR. Surprisingly, and Lin et al. [1997] for TCRs of uncharacterized speci-
ficities). In contrast, selection and function of other TCRseven upon massive TCR/CD3 cross-linking, the phos-
phorylation of the tyrosines left in both za12b12c12 and may more strictly require the presence of a quasi-normal
complement of CD3/ITAMs (e.g., the H-Y TCR analyzedza1b1c22 does not proceed substantially. In the case of
za12b12c12, this may stem in part from the fact that the by Shores et al., 1998). It should be stressed, however,
that z ITAMs still appear to be required to optimize someZAP-70 tandem SH2 domains are no longer capable of
protecting the remaining tyrosines from ongoing de- responses (e.g., proliferation or IFNg secretion) when
P14 TCR1 T cells were challenged with peptide concen-phosphorylation (Scharenberg et al., 1995; MeÁ ge et al.,
1996), whereas in za1b1c22 subunits, the lack of tyrosine trations close to the end point of the dose-response
curves. Second, by engineering mice in which bothc2 may affect the interdependent and ordered tyrosine
phosphorylation reactions that lead from basal to full z CD3-z and CD3-e ITAMs were rendered nonfunctional,
we recently showed that for most TCRs there is a thresh-phosphorylation (Neumeister Kersh et al., 1998). Alto-
gether, these data suggest that the CD3-z ITAMs, and by old below which the number of associated CD3-ITAMs
cannot be reduced further without impairing signalinginference the hierarchical phosphorylation they normally
undergo upon TCR engagement, are dispensable to pro- capacity (L. A. and M. M., unpublished data). Irrespective
of these quantitative considerations, our results un-duce a diverse range of T cell responses. Along the
same line, it should be noted that when stimulated with equivocally suggest that during antigen-driven CD81 T
cell responses, the ITAMs present in the CD3-gde mod-high- and low-affinity ligands, the BCR and the FceRI
can also produce a diverse range of responses without ule are sufficient for qualitatively normal TCR signaling.
Whether this is also the case for the CD3-z module,incorporating transducing subunits with concatenated
ITAMs or relying on differential ITAM phosphorylation however, remains to be determined using a reciprocal
approach to the one outlined in this paper.(Torigoe et al., 1998; Kouskoff et al., 1998).
The P14 TCR has been selected in a normal thymus
Experimental Proceduresand thereby calibrated in the context of T cells express-
ing a full complement of CD3-ITAMs. Accordingly, we
cDNA Constructswere expecting dramatically higher EC50 values for the
The various z chain cDNAs were assembled by PCR and cloned
dose-response curves generated in the absence of func- in the pTEX vector. Lines were established by backcrossing the
tional z ITAMs. This was not the case, and even when founders with C57BL/6 mice.
assaying Ca21 responses and thus reaching an excellent
Miceresolution in time, the absence of functional z ITAMs
P14 TCR transgenic mice (line 327, Pircher et al., 1989) and CD3-was unnoticeable. Considering that we have failed to
z/h2/2 mice (Malissen et al., 1993) were maintained on a C57BL/6document yet any blatant changes aiming at compen-
background.
sating the crippled z ITAMs (e.g., the downregulation of
CD5 [data not shown] or the overexpression of the CD8 Flow Cytometric Analysis
coreceptor or of some of the proximal TCR effectors Flow cytometric analysis was performed as described (Malissen et
al., 1995). Antibodies against CD3 (2C11), CD4 (GK1.5), CD8a (56±[Lck, ZAP-70, LAT]), it remains possible that CD3-ITAMs
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6.7), Va2 (B20.1), CD25 (7D4), CD69 (H1.2F3), CD95 (Jo2), and CD95L determine the levels of Va2, CD3-e, CD25, CD69, CD95, or CD95L.
The extent of TCR downregulation on CD81 T cells was normalized(Kay-10) were purchased from Pharmingen.
using the following formula: % TCR downregulation 5 100 2 [(TCR
mean fluorescence intensity in response to an RMA-S loaded withAntibodies
a given peptide concentration/TCR mean fluorescence intensity inThe following antibodies were used for immunoprecipitations and
response to RMA-S loaded with the same concentration of the nega-Western blotting: 145±2C11 (2C11), anti-CD3-e (Leo et al., 1987);
tive control AV peptide) 3 100].HAM25 1157.14, anti-CD3-e (a gift of R. Kubo); H146±968, anti-CD3-z
raised against a synthetic peptide corresponding to amino acids
Cytotoxic T Cell Responses151±164 (Rozdzial et al., 1995); rabbit anti-LAT (UBI, USA); rabbit
CD81 splenic T cells (1.5 3 106) were cultured with 3 3 106 irradiatedanti-z serum 387 (specific for amino acids 132±144; a gift of L.
C57BL/6 spleen cells pulsed with p33. After 3 days, cells wereSamelson); rabbit anti-FceRIg (Orloff et al., 1990); rabbit anti-ZAP-
counted and adjusted to the required number before being tested70; rabbit anti-CD3-e (DAKO A/S, Glostrup, Denmark); and 4G10,
in 51Cr-release assay. Standard 4 hr chromium release assays wereanti-phosphotyrosine (Upstate Biotechnology).
performed using 51Cr-labeled, peptide-pulsed RMA-S target cells.
Percent specific lysis was calculated as 100 3 [(experimental 2Surface Labeling, Immunoprecipitation, SDS-Polyacrylamide
spontaneous 51Cr release)/(total 2 spontaneous 51Cr release)].Gel Electrophoresis, and Immunoblotting
Surface radioiodination of T cells (1.5 3 107) was performed on ice
Analysis of IFNg and IL-2 Productionfollowing a step of digitonin permeabilization aimed at increasing
For measurement of IFNg secretion, microplates were coated withthe labeling of z chains. Lysis in 1% Brij 96, immunoprecipitation
the anti-mouse IFNg antibody R4±6A2 (Pharmingen) and blockedand 2D diagonal gel analysis were performed as described (Luton
with 1% BSA in PBS for 2 hr. After addition of supernatant (50 ml)et al., 1997). Prior to pervanadate treatment, lymph node T cells
from 40 hr cultures (1 hr, 48C), and incubation with the biotinylated(1 3 107) were rested for 2 hr at 378C. Pervanadate was prepared
anti-mouse IFNg antibody XMG1.2 (Pharmingen), bound XMG1.2as described (Donnadieu et al., 1994) and T cells were stimulated
molecules were detected with avidin peroxydase and the ABTSat 378C for 7 min with a 50 mM final concentration. After lysis in 1%
substrate. Absorption values were converted into IFNg units usingBrij 96, TCR complexes were immunoprecipitated with the anti-
a recombinant mouse IFNg standard (Genzyme). For IL-2 measure-CD3-e antibody 2C11 and separated on SDS-PAGE. Separated pro-
ments, supernatants from 40 hr cultures were assayed for their levelteins were transferred to Immobilon-PC Millipore membrane in
of IL-2 using the CTL-L line. Values were converted into IL-2 unitsCAPS buffer (pH 11) and visualized as described (Luton et al., 1997).
using a recombinant mouse IL-2 standard (Pharmingen).
Isolation of DIMs
Antagonist AssaysDIMs analysis was performed as described (Montixi et al., 1998).
They were essentially performed as described (Bachmann et al.,
1998). Briefly, spleen cells from H-2 Db-positive CD3-e-deficient micePeptides
were pulsed with suboptimal concentrations of peptides (p33 orPeptides p33 (KAVYNFATM), M3V (KAMYNFATM), L3V (KALYN-
M3V) for 1 hr, washed, and distributed in flat-bottom 96-well plates.FATM), S4Y(KAVSNFATM), V4YL6F (KAVVNLATM), and the adenovi-
Graded concentrations of antagonistic peptides (S4Y or V4YL6F) orrus peptide AV (SGPSNTPPEI) have been described previously
of a control H-2 Db-binding peptide (AV) were added to the wells.(Pircher et al., 1991). Peptides M3V and L3V have been previously
After 30 min, 5 3 104 CD81 T cells purified from P14, za12b12c12, orreferred to as LCMV8.1 and LCMV 8.7, respectively (Pircher et al.,
za1b1c22 mice were added per well. After 48 hr, proliferation was1991).
assessed by incorporation of [3H]thymidine for 8 hr.
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